FBR & Co currently has a “Outperform” rating and a $7.00 price target on the stock. Get pSivida Corp. alerts: COPYRIGHT VIOLATION NOTICE: “pSivida Corp. (PSDV) Forecasted to Earn FY2021 Earnings of $1.47 Per Share” was reported by …
BNS7d
PSivida
Disclosure: I am/we are long PSDV. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking …
Clinical Trial
pSivida Corp. (NASDAQ:PSDV)‘s stock had its “outperform” rating reaffirmed by FBR & Co in a research note issued on Monday. They currently have a $7.00 target price on the stock. FBR & Co’s target price indicates a potential upside of …
BP Prudhoe Bay Royalty Trust (BPT): BPT stock is up 4.71% today. Constellation Brands Inc (STZ): STZ stock is up 4.35% today. Psivida Corp (PSDV): PSDV stock is up 3.63% today. Some of the biggest losers among Manufacturing …
Civil Aviation Authority of Singapore
pSivida Corp. (NASDAQ:PSDV) is having an incredible day in the market today after posting solid data from a recent Phase 3 clinical trial. As a result of the solid data, a big opportunity for revenue is likely to open in the near future. …
pSivida Corp. (PSDV) was a big mover last session, as its shares rose roughly 32% on the day. This continues the uptrend for the company since Dec 9, as the stock is now up nearly 49%. In the last 30 days, the company did not …
A better-ranked stock in the same industry is Achillion Pharmaceuticals, Inc. ( ACHN), sporting a Zacks Rank #1 (Strong Buy). Is PSDV going up? Or down? Predict to see what others think: Up or Down Want the latest recommendations …
FBR & Co reaffirmed their outperform rating on shares of pSivida Corp. (NASDAQ:PSDV) in a research note published on Monday. They currently have a $7.00 price target on the stock. pSivida Corp. (NASDAQ:PSDV) traded down 1.92% …
pSivida is having an incredible day in the market today after posting solid data from a recent Phase 3 clinical trial. As a result of the solid data, a big opportunity for revenue is likely to open in the near future. Today, we'll talk about the data …